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Abstract Cell expansion, gene transfer and pro-
tein production were all executed with a single
serum-free, animal protein-free commercial med-
ium designed for suspension-adapted Chinese
hamster ovary cells (CHO DG44). This is a most
important process to consider for clinical produc-
tion of recombinant proteins. The transfection
with polyethylenimine (PEI) was shown here to
be scalable using both stirred-tank bioreactors of
3- and 150-l and novel agitated cultivation vessels
(50 ml ventilated centrifuge tubes and 1-l square-
shaped glass bottles) that lack any instrumenta-
tion. The transient transfections spanned a range
of working volumes from 2 ml to 80 l. The
maximum transient recombinant antibody yield
was 22 mg/l, the highest ever reported for a
multiliter transfection in CHO. The transiently
expressed protein had the same extent of glyco-
sylation as the same antibody produced from a
stably transfected recombinant CHO cell line.
Keywords Antibody  Bioreactor  Orbital
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Introduction
Using low cost DNA delivery agents, such as
calcium phosphate (Jordan et al. 1996) and poly-
ethylenimine (PEI) (Boussif et al. 1995), suspen-
sion cultures of mammalian cells at volumes up to
100 l have been transfected for the transient
production of recombinant proteins. The two
major hosts for these processes are human
embryo kidney (HEK 293) and Chinese hamster
ovary (CHO) cells with the volumetric yields of
secreted recombinant proteins being higher with
HEK 293 cells (Schlaeger and Christensen 1999;
Meissner et al. 2001; Girard et al. 2002; Pham
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et al. 2003; Schlaeger et al. 2003; Derouazi et al.
2004; Tait et al. 2004; Pham et al. 2005; Rosser
et al. 2005; Baldi et al. 2005; Galbraith et al.
2006). Transient gene expression has been per-
formed in several non-instrumented cultivation
systems including multiwell plates (Girard et al.
2001; Derouazi et al. 2004), spinner flasks
(Schlaeger and Christensen 1999; Meissner et al.
2001; Rosser et al. 2005; Baldi et al. 2005), and
shake-flasks (Tait et al. 2004; Rosser et al. 2005)
as well as in stirred-tank bioreactors (Girard et al.
2002; Derouazi et al. 2004).
For regulatory reasons, it is necessary to
transiently express recombinant proteins destined
for therapeutic applications in chemically defined
conditions without animal-derived components
such as serum. The elimination of these compo-
nents reduces the risk of contamination of the
recombinant protein with infectious agents. The
elimination of serum in particular facilitates the
purification of secreted recombinant proteins
and reduces the cost and variability of the
production process. These restrictions, however,
may limit the scope of transient gene expression
technology. The absence of serum, for example,
substantially reduces the efficiency of calcium
phosphate-mediated transfection (Jordan et al.
1996). PEI-mediated DNA transfer, on the other
hand, is serum-independent (Pham et al. 2003;
Derouazi et al. 2004; Tait et al. 2004; Rosser et al.
2005), and it can be performed in minimal media
or in complex media formulated for serum-free
suspension cultures (Derouazi et al. 2004; Tait
et al. 2004; Rosser et al. 2005).
Here we report the PEI-mediated transfection
of CHO cells in a medium formulated for high-
density suspension growth of this cell line in the
absence of animal-derived components. The
method was shown to be scalable over a broad
range of working volumes using both non-instru-
mented and instrumented cultivation systems that
included two novel shaken vessels, 50-ml venti-
lated centrifuge tubes and 1-l square-shaped glass
bottles, which have previously been shown to
support growth of CHO cells to high densities
(De Jesus et al. 2004; Muller et al. 2005). The
development of a scalable transient gene expres-
sion method for CHO cells using a single medium
for both cell cultivation and transfection is
expected to facilitate the transient production of
recombinant proteins in this cell line.
Materials and methods
Cell culture
Suspension-adapted CHO DG44 cells (a dihy-
drofolate reductase deficient mutant) were rou-
tinely cultivated in 1-l square-shaped glass bottles
(Schott Glass, Mainz, Germany) in ProCHO5
CDM medium (Cambrex, East Rutherford, NJ)
supplemented with 4 mM glutamine, 0.68 mg
hypoxanthine/l, and 0.194 mg thymidine (GHT)/l
as previously described (Muller et al. 2005). One
day prior to transfection, unless otherwise stated,
the cells were transferred in to 400 ml fresh
ProCHO5 CDM medium with GHT to give
1 · 106 cells/ml. The packed cell volume (PCV)
was determined using mini-PCV tubes (TPP,
Trasadingen, Switzerland) as previously described
(Stettler et al. 2006).
Plasmids
pEAK8-LH39 and pEAK8-LH41 carrying the
full-length cDNAs of the anti-Rhesus D light and
heavy chain IgG genes, respectively, were
described previously (Pick et al. 2002). pEAK8
was purchased from Edge Biosystems (Gaithers-
burg, MD). pEGFP-N1 was purchased from
Clontech (Palo Alto, CA). Plasmid DNA was
purified on a Nucleobond AX anion exchange
column (Macherey-Nagel, Du¨ren, Germany)
according to the manufacturer’s protocol.
Transfection
Linear 25 kDa PEI (pH 7.0) (Polysciences,
Eppenheim, Germany) was prepared in water at
1 mg/ml and sterilized by filtration. For each ml
of culture, 2.5 lg DNA and varying amounts of
PEI were added separately to 50 ll 150 mM
NaCl. Prior to addition to the culture, the PEI
solution was added to the DNA solution and
allowed to stand at room temperature for 10 min
(Derouazi et al. 2004). Unless otherwise indi-
cated, the transfections were performed with a
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mixture of pEAK8-LH41, pEAK-LH39, and
pEGFP-N1 at 68:30:2 (by wt) for optimal expres-
sion of IgG and GFP as described previously
(Pick et al. 2002).
For transfections in 12-well plates, the cells
were centrifuged and resuspended in either RPMI
1640 (Applichem, Darmstadt, Germany) contain-
ing 25 mM HEPES (pH 7.1) or ProCHO5 CDM
with GHT. Aliquots of 1 ml were then distributed
at a density of 1–2 · 106 cells/ml into 12-well
plates. After transfection the cultures were incu-
bated at 37C in 5% CO2 with 90% humidity with
agitation on an orbital shaker at 180 rpm (Girard
et al. 2001). After 4 h, one volume of medium was
added to each well.
For transfections in 50 ml ventilated centrifuge
tubes (TPP) (De Jesus et al. 2004), the cells were
centrifuged and resuspended in ProCHO5 CDM
with GHT. Aliquots of 5 ml were added to each
50 ml tube at 2 · 106 cells/ml. Following DNA
addition, the tubes were shaken at 140 rpm at
37C in 5% CO2 with 85% humidity. After 4 h,
one volume of medium was added and the
agitation speed was increased to 160 rpm.
For transfections in 1 l square-shaped glass
bottles, the cells were centrifuged and resus-
pended at 2 · 106 cells/ml in 200 ml of either
RPMI 1640 containing 25 mM HEPES (pH 7.1)
and 0.1% (w/v) Pluronic F-68 (Applichem,
Darmstadt, Germany) or ProCHO5 CDM with
GHT. Following DNA addition, the bottles were
shaken at 110 rpm at 37C in 5% CO2 with 85%
humidity with the bottle caps opened one quarter
of a turn. After 4 h, one volume of medium was
added. At 24 h post-transfection, the bottles were
shaken at 110 rpm at 37C without CO2 and
humidity control. The cultures were fed upon
need with glucose to 4 g/l, glutamine to 4 mM,
and sodium bicarbonate to 10 mM.
For transfections in bioreactors, the cells were
centrifuged and resuspended in either ProCHO5
CDM with GHT or RPMI 1640 with 25 mM
HEPES (pH 7.1) and 0.1% (w/v) Pluronic F-68
and transferred to a 3 l bioreactor (Applikon,
Knuellwald, The Netherlands) or a 150 l biore-
actor (Bioengineering, Wald, Switzerland) con-
taining sufficient prewarmed medium to give
2 · 106 cells/ml. Transfection was performed
immediately after seeding and the cultures were
stirred at 150 rpm. After 4 h, one volume of
ProCHO5 CDM with GHT was added, and the
agitation speed was increased to 200 rpm. The pH
was maintained at 7.1 using NaOH and CO2, and
dissolved O2 was maintained at 20% by sparging
air into the culture. As described above, the
cultures were fed upon need with glucose, gluta-
mine, and sodium bicarbonate.
Protein analysis
GFP expression was measured with a Cytoflour
4000 plate-reading fluorometer (PerSeptive Bio-
systems, Inc., Farmington, MA) after lysis of the
cells by addition of Triton X-100 to give 0.1%
(Hunt et al. 1999). The IgG concentration in the
culture medium was determined by sandwich
ELISA as previously described (Meissner et al.
2001). For glycosylation analysis, IgG was puri-
fied by affinity chromatography using a Stream-
line protein A column (Amersham GE
Healthcare, Switzerland). The column was equil-
ibrated with 5 bed volumes of 50 mM sodium
phosphate (pH 7.0). After sample loading, the
column was washed with 10 column volumes of
the same buffer. IgG was eluted with 2 bed
volumes of 0.1 M sodium citrate (pH 3.0) and
immediately buffered with 10% (v/v) of 1 M
Tris/HCl (pH 8.0). The samples were desalted
and concentrated with Microcon Y-10 filters
(Millipore) and then treated with peptide N-
glycosidase F (PNGase F) (QAbio, Palm Desert,
CA) according to the manufacturer’s protocol.
SDS-PAGE was performed with a NuPAGE 4–
12% polyacrylamide gradient gel (Invitrogen)
and stained with Coomassie Blue.
Results
Determination of transfection parameters in
12-well plates
The feasibility of transfecting directly in
ProCHO5 CDM medium was initially investi-
gated in 12-well plates. In these experiments three
parameters, the DNA:PEI ratio, the cell density,
and the age of the culture at the time of
transfection were varied. To determine the
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optimum DNA:PEI ratio, the cells in either
ProCHO5 CDM or RPMI 1640 were transfected
with a mixture of pEAK-LH41, pEAK-LH39,
and pEGFP-N1. The final DNA concentration
was kept constant at 2.5 lg/ml, and the DNA:PEI
ratio was varied from 1:2 to 1:6 (w/w). For the
transfections in ProCHO5 CDM, DNA:PEI ratios
of 1:4 and 1:5 (w/w) resulted in the highest levels
of GFP and antibody expression (Table 1). By
comparison the highest protein yields for the
transfections in RPMI 1640 were observed at a
DNA:PEI ratio of 1:2 (w/w) (Table 1; only the
results from the transfection at a DNA:PEI ratio
of 1:2 are shown). Slightly higher levels of both
GFP and antibody were observed for the trans-
fections in ProCHO5 CDM as compared to those
in RPMI 1640 (Table 1).
Using a DNA:PEI ratio of 1:4 (w/w), the effect
of cell density on transient recombinant protein
expression in ProCHO5 CDM was investigated.
Cells at either 1 or 2 · 106 cells/ml were trans-
fected as described above. At 3 d post-transfec-
tion, the highest level of antibody accumulation
(4.9 ± 0.6 mg/l) was observed at a density of
2 · 106 cells/ml. Subsequent experiments in other
cultivation systems were therefore performed at
this cell density.
To determine the effect of culture age on
transient gene expression, the cells were culti-
vated in ProCHO5 CDM for 1–7 d prior to
transfection. On the day of transfection, the
density of each culture was approximately
3 · 106 cells/ml. The cells from each culture were
either centrifuged and resuspended in fresh Pro-
CHO5 CDM or maintained in conditioned
medium. In either case, the cells were seeded at
2 · 106 cells/ml in 12-well plates and transfected
with a mixture of 10% pEAK8 and 90% pEG-
FPN-1 at various DNA:PEI ratios. The level of
GFP expression at 3 d post-transfection was
dependent on the age of the culture at the time
of transfection (Fig. 1). With an increase in
cultivation time, a decrease in GFP expression
was observed. In addition, the transfer of cells
into fresh medium at the time of transfection was
necessary for efficient PEI-mediated gene trans-
fer; little GFP expression was observed following
the transfection of the one-day old culture (N–1) in
conditioned medium (Fig. 1). Furthermore, the
transfection of four- and seven-day old cultures in
conditioned medium did not result in significant
levels of GFP expression using DNA:PEI ratios
up to 1:9 (w/w) (data not shown). It was
concluded that for PEI-mediated transfection in
ProCHO5 CDM, it was preferable to use cells
that were maintained for only 1 d in this medium
Table 1 Effect of PEI:DNA ratio on transient gene
expression
DNA:PEI ratio (w/w)a GFP (RFU)b IgG (mg/l)c
1:2 R 2550 ± 180 5.3 ± 0.7
1:2 860 ± 260 1.7 ± 0.9
1:3 1690 ± 290 4.5 ± 0.2
1:4 3000 ± 390 6.9 ± 0.5
1:5 2850 ± 140 6.9 ± 0.2
1:6 2750 ± 150 5.0 ± 0.1
aCells were seeded at 2 · 106 cells/ml in either ProCHO5
CDM or RPMI 1640 (R) and transfected with pEAK8-
LH39, pEAK8-LH41, and pEGFP-N1 at various DNA:
PEI ratios as indicated
b The relative fluorescence units (RFU) were determined
by fluorometry after cell lysis at 3 d post-transfection. The
average of three transfections is shown
c IgG concentration in cell culture medium was measured
by ELISA at 3 d post-transfection. The average of three
transfections is shown
Fig. 1 Effect of culture age on transient gene expression.
CHO DG44 cells grown in ProCHO5 CDM for either one
(N–1), four (N–4), or seven (N–7) days were either
centrifuged and resuspended in fresh ProCHO5 CDM
ximmediately before transfection or were transfected
directly in the conditioned medium. The cells were seeded
in 12-well plates at 2 · 106 cells/ml and transfected with a
mixture of 90% pEAK8 and 10% pEGFPN-1 at various
DNA:PEI ratios. The cells were diluted with one volume
of ProCHO5 CDM at 4 h post-transfection. GFP expres-
sion was measured at 3 d post-transfection. The average of
three transfections is shown
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before passage to fresh medium immediately
before transfection.
Transfections in 50-ml ventilated centrifuge
tubes
Cells in 2.5 ml of ProCHO5 CDM were trans-
fected at a DNA:PEI ratio of 1:4 (w/w). The
cultures were either fed with glucose (to 4 g/l)
and glutamine (to 4 mM) upon need or left unfed.
By 5 d post-transfection, the level of antibody was
similar for both fed and unfed cultures (Fig. 2A).
However, the biomass of the fed culture was
higher than that of the unfed culture at 5–7 d
post-transfection (Fig. 2B). These results demon-
strated that the feeding of glucose and glutamine
is not necessary following transfection in this
vessel if the cultures are only maintained for up to
7 d.
Transfections in 1-liter square-shaped bottles
The cells were transfected at a DNA:PEI ratio of
either 1:2 or 1:4 (w/w) in RPMI 1640 or ProCHO5
CDM, respectively. At 5 d post-transfection, the
IgG yield for the transfection in ProCHO5 CDM
was almost twice that for the one in RPMI 1640
(Fig. 3). The higher antibody level in ProCHO5
CDM was not due to a greater accumulation of
biomass since there was not a significant differ-
ence in the % PCV between the two cultures
(data not shown). The approximate specific pro-
ductivities for the transfections in ProCHO5
CDM and RPMI 1640 were 1.3 and 0.7 pg/cell d,
respectively. Similar results to those shown in
Fig. 3 were observed for transfections in 250-ml
square-shaped glass bottles (data not shown).
Subsequent to this experiment the transfection in
square-shaped bottles was further simplified by
demonstrating that incubation in the presence of
CO2 was not necessary as long as the bottle caps
were tightly closed for 24 h post-transfection and
then opened about one quarter of a turn for the
remainder of the cultivation period (data not
shown).
Fig. 2 Transfection in 50 ml centrifuge tubes. CHO DG44
cells were seeded in duplicate in 50 ml tubes in 2.5 ml of
ProCHO5 CDM and transfected with a mixture of
pEAK8-LH39, pEAK8-LH41, and pEGFP-N1 at a
DNA:PEI ratio of 1:4 (w/w). At 4 h post-transfection,
one volume of ProCHO5 CDM was added to each tube.
The cultures were either maintained without feeding (no
feeding) or were fed upon need with glutamine and
glucose (feeding). At the times indicated the antibody
concentration in the culture medium was determined by
ELISA (A) and the packed cell volume (% PCV) was
determined with a mini-PCV tube (B)
Fig. 3 Transfection in 1 l square-shaped bottles. CHO
DG44 cells were seeded in duplicate in either ProCHO5
CDM or RPMI 1640 in 1 l square bottles. The cells were
transfected with a mixture of pEAK8–LH39, pEAK8–41,
and pEGFP-N1 at a DNA:PEI ratio of either 1:4 (w/w) in
ProCHO5 CDM or 1:2 (w/w) in RPMI 1640. At the times
indicated the antibody concentration in the medium was
determined by ELISA
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Transfections in bioreactors
The cells were seeded in 3-l bioreactors at
2 · 106 cells/ml in 500 ml of either ProCHO5
CDM or RPMI 1640 as described in the previous
section. By 7 d post-transfection, the antibody
yield reached 18 mg/l for the transfection in
ProCHO5 CDM and 12 mg/l for that in RPMI
1640 (Fig. 4A). The biomass for the two cultures
was about the same until day 4 (Fig. 4B). For
both cultures the cell viability was above 90%
through day 6 post-transfection (Fig. 4C). Sur-
prisingly, there was little increase in IgG
accumulation after day 5 for either culture despite
the fact that the biomass increased from 0.9% to
1.2% PCV for the transfection in ProCHO5 CDM
during this period (Fig. 4C). Despite the differ-
ence in antibody yield for the two cultures, the
specific productivities, 0.9 pg/cell d in ProCHO5
CDM and 0.8 pg/cell d in RPMI 1640, were about
the same.
For the transfection in a 150 l bioreactor, the
cells were seeded in 40 l of ProCHO5 CDM at
2 · 106 cells/ml, and the culture was transfected
at a DNA:PEI ratio of 1:4 (w/w). The antibody
yield (22 mg/l) was similar to that observed in 3 l
bioreactors (Fig. 5A). The cell density reached a
maximum of 4 · 106 cells/ml at 3–4 d post-trans-
fection and then declined (Fig. 5B). In contrast to
the results in 3 l bioreactors, the viability of the
culture decreased rapidly after day 4 and eventu-
ally fell to 50% by day 6 (Fig. 5B). The specific
productivity was 1 pg/cell.d.
Transiently produced anti-Rhesus D IgG from
the 150 l bioreactor and the same antibody
expressed from a recombinant CHO cell line
(CHO AMW) (MJ De Jesus and FM Wurm,
unpublished data) were purified by protein
A-based affinity chromatography. These samples
plus IgG from a commercial source (Jackson
ImmunoReasearch) were deglycosylated with
PNGase F, an enzyme that catalyzes the release
of N-linked oligosaccharides from proteins. The
heavy chain of the anti-Rhesus D IgG, regardless
if it was expressed transiently or stably from CHO
cells, had about 3 kDa of glycosylation judging
from the band shift of the heavy chain with and
without PNGase F treatment (Fig. 6). As a
comparison, the heavy chain of the unrelated
commercial IgG had about 2 kDa of glycosylation
(Fig. 6).
Discussion
Transient gene expression in mammalian cells is a
promising approach to the generation of
Fig. 4 Transfection in 3 l bioreactors. CHO DG44 cells
were seeded in duplicate in 500 ml of either ProCHO5
CDM or RPMI 1640 in 3 l bioreactors. The cultures were
transfected with a mixture of pEAK8–LH39, pEAK8–
LH41, and pEGFP-N1 at a DNA:PEI ratio of either 1:4
(w/w) in ProCHO5 CDM or 1:2 (w/w) in RPMI 1640. The
cultures were diluted with one volume of ProCHO5 CDM
after 4 h. At the times indicated the antibody concentra-
tion in the medium was measured by ELISA (A), the
packed cell volume (% PCV) was determined with a mini-
PCV tube (B), and cell viability was determined with the
Trypan Blue exclusion method (C)
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milligram to gram quantities of recombinant
proteins. Here we describe a transient gene
expression method that is applicable to both
instrumented and non-instrumented cultivation
systems at a broad range of scales. We have
previously described PEI-mediated transfection
of suspension-adapted CHO DG44 cells in serum-
free minimal medium (RPMI 1640) in which
antibody yields in the range of 2–6 mg/l were
achieved at volumes up to 13 l (Derouazi et al.
2004). For those experiments, ProCHO5 CDM, a
medium formulated for high-density growth of
CHO cells in the absence of animal-derived
components, was used for cell cultivation but
the transfection itself was performed in RPMI
1640 with a dilution in ProCHO5. Here the latter
was used for the entire bioprocess. When com-
pared directly, recombinant protein expression
was higher for transfections in ProCHO5 CDM
than in RPMI 1640. The improved method
yielded similar levels of recombinant antibody
in both standard stirred bioreactors and agitated
non-instrumented cultivation systems including
50 ml ventilated centrifuge tubes and 1 l square-
shaped glass bottles.
The agitated square-shaped bottle is an attrac-
tive option for both cell cultivation and transient
transfection. For routine cultivation of CHO cells,
densities of 5 · 106 cells/ml are typically achieved
(Muller et al. 2005). The transfections in 1 l
square bottles described here yielded about
20 mg/l of antibody as compared to yields of 18
and 22 mg/l in 3- and 150 l bioreactors, respec-
tively. Importantly, this simple cultivation system
does not require instrumented control of the O2,
CO2, and pH levels. Thus, agitated square-shaped
bottles may eventually become an alternative to
instrumented bioreactors for transient gene
expression in mammalian cells. Although only
results from transfections in 1 l bottles are
provided here, we have also cultivated and
Fig. 5 Transfection in a 150-l bioreactor. CHO DG44 cells
were seeded in 40 l of ProCHO5 CDM. The cells were
transfected with a mixture of pEAK8–LH39, pEAK8–
LH41, and pEGFP-N1 at a DNA:PEI ratio of 1:4 (w/w)
and then diluted with one volume of ProCHO5 CDM at
4 h post-transfection. At the times indicated the antibody
concentration was determined by ELISA (A) and the
viable cell number and the percent viability were deter-
mined by manual counting with the Trypan blue exclusion
method (B)
Fig. 6 SDS-PAGE analysis of IgG glycosylation. Anti-
Rhesus D IgG from the transient transfection in the 150-l
bioreactor (lanes 1 and 2) and from CHO AMW (lanes 3
and 4) were affinity purified. These samples and a
commercial IgG (lanes 5 and 6) were deglycosylated with
PNGase F. Protein samples before (lanes 1, 3, and 5) and
after treatment with PNGase F (lanes 2, 4, and 6) were
electrophoresed on a 4–12% polyacrylamide gradient gel.
The molecular weight marker is shown in the left lane
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transfected CHO cells in both smaller and larger
square- and round-shaped containers of either
glass or plastic (M Stettler and FM Wurm,
unpublished data).
The 50 ml ventilated centrifuge tubes
described here provide a convenient cultivation
system for high-throughput, small-scale transfec-
tions. They offer advantages over agitated multi-
well plates in having a very low evaporation rate
under humidified cultivation conditions and a
working volume up to 20 ml per tube. They also
support the routine cultivation of CHO cells to
densities of 8–10 · 106 cells/ml (M Stettler and
FM Wurm, unpublished data) and are suitable for
the multiparameter screening of bioprocess con-
ditions (De Jesus et al. 2004). Importantly, the
transient recombinant protein yields in these
tubes were similar to those achieved in standard
stirred tank bioreactors, demonstrating the scala-
bility of processes optimized in this disposable
vessel.
The highest transgene expression levels in
ProCHO5 CDM and RPMI 1640 were achieved
by transfection at DNA:PEI ratios of 1:4 (w/w)
and 1:2 (w/w), respectively. One possible expla-
nation for this difference is the presence of one or
more components in ProCHO5 CDM which
interact with PEI. If PEI has a higher affinity
for a component(s) in the medium than it does for
DNA, then the active transfection complex may
be disrupted, resulting in a decrease in the
efficiency of gene delivery (Godbey et al. 1999).
Indeed, it has been shown that PEI forms a
precipitate with an unknown component(s) in
ProCHO5 CDM (M Bertschinger and FM Wurm,
unpublished data). Thus, transfection in this
medium may require addition PEI to prevent
disassembly of the preformed PEI/DNA
complexes.
The transient antibody yields achieved here are
among the highest reported for CHO cells.
Certainly, the 22 mg antibody/l produced in an
80 l transfection is the highest reported for a
multiliter process. These results demonstrate the
feasibility of producing gram amounts of recom-
binant antibody by transient transfection of CHO
cells. By comparison, recombinant CHO cell lines
may yield as much as 4 g antibody/l with specific
productivities of 50 pg/cell d or more (Wurm
2004). These differences in recombinant protein
yield suggest that further improvements in tran-
sient gene expression in mammalian cells are
possible. Optimization of media, gene delivery
methods, cultivation systems, and expression
vectors are expected to close this gap, making
transient gene expression an even more attractive
option for the rapid production of recombinant
proteins.
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